303 related articles for article (PubMed ID: 25424750)
21. Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function.
Radice GL; Sauer CL; Kostetskii I; Peralta Soler A; Knudsen KA
Differentiation; 2003 Aug; 71(6):361-73. PubMed ID: 12919105
[TBL] [Abstract][Full Text] [Related]
22. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
[TBL] [Abstract][Full Text] [Related]
23. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
24. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
Dias Pereira P; Carvalheira J; Gärtner F
Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
[TBL] [Abstract][Full Text] [Related]
25. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.
Seixas F; Palmeira C; Pires MA; Bento MJ; Lopes C
Vet J; 2011 Jan; 187(1):65-71. PubMed ID: 19955006
[TBL] [Abstract][Full Text] [Related]
26. Expression of the Short Form of RON/STK in Feline Mammary Carcinoma.
Maniscalco L; Guil-Luna S; Iussich S; Gattino F; Trupia C; Millan Y; de Las Mulas JM; Cespedez RS; Saeki K; Accornero P; De Maria R
Vet Pathol; 2019 Mar; 56(2):220-229. PubMed ID: 30558510
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
28. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
Seixas F; Pires MA; Lopes CA
Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
[TBL] [Abstract][Full Text] [Related]
29. Aberrant subcellular immunolocalization of NOTCH-1 activated intracellular domain in feline mammary tumours.
Ressel L; Else RW; Poli A; Argyle DJ
J Comp Pathol; 2014 May; 150(4):366-72. PubMed ID: 24529510
[TBL] [Abstract][Full Text] [Related]
30. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas.
Flores AR; Rêma A; Carvalho F; Lopes G; Faustino A; Dias Pereira P
J Comp Pathol; 2014 Nov; 151(4):339-46. PubMed ID: 25246182
[TBL] [Abstract][Full Text] [Related]
32. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
[TBL] [Abstract][Full Text] [Related]
33. P-cadherin expression in feline mammary tissues.
Figueira AC; Teodósio AS; Carvalheira J; Lacerda M; de Matos A; Gärtner F
Vet Med Int; 2012; 2012():687424. PubMed ID: 23091776
[TBL] [Abstract][Full Text] [Related]
34. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands.
Torres LN; Matera JM; Vasconcellos CH; Avanzo JL; Hernandez-Blazquez FJ; Dagli ML
Vet Pathol; 2005 Sep; 42(5):633-41. PubMed ID: 16145209
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma.
Pisamai S; Rungsipipat A; Kunnasut N; Suriyaphol G
J Comp Pathol; 2017; 157(2-3):150-162. PubMed ID: 28942298
[TBL] [Abstract][Full Text] [Related]
36. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.
Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K
Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797
[TBL] [Abstract][Full Text] [Related]
38. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours.
Petterino C; Podestà G; Ratto A; Drigo M; Pellegrino C
Vet Res Commun; 2007 Feb; 31(2):173-84. PubMed ID: 17186410
[TBL] [Abstract][Full Text] [Related]
40. Prognostic histopathological and molecular markers in feline mammary neoplasia.
Hughes K; Dobson JM
Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
